Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
44.50
-0.20 (-0.45%)
At close: Dec 3, 2025

Orient EuroPharma Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
4,5314,3914,5924,7304,7675,384
Upgrade
Revenue Growth (YoY)
1.36%-4.37%-2.93%-0.77%-11.45%-11.65%
Upgrade
Cost of Revenue
2,3312,3252,4452,6982,6162,962
Upgrade
Gross Profit
2,2012,0662,1472,0322,1512,422
Upgrade
Selling, General & Admin
1,8821,8111,8681,9221,9181,938
Upgrade
Research & Development
407.07242.22206.6259.84331.09366.56
Upgrade
Operating Expenses
2,3042,0732,0772,1822,2462,305
Upgrade
Operating Income
-103.04-6.7270.61-149.54-95.68117.36
Upgrade
Interest Expense
-87.23-107.23-106.1-69.53-38.04-30.23
Upgrade
Interest & Investment Income
31.9348.8750.8620.9611.8516.04
Upgrade
Earnings From Equity Investments
-55.54-27.29-18.27-30.14-19.14-16.88
Upgrade
Currency Exchange Gain (Loss)
-29.38-111.86-25.59-177.5111.6125.63
Upgrade
Other Non Operating Income (Expenses)
62.2471.1150.0840.5441.6936.45
Upgrade
EBT Excluding Unusual Items
-181.02-133.121.6-365.23-87.71248.36
Upgrade
Gain (Loss) on Sale of Investments
6.156.15----
Upgrade
Gain (Loss) on Sale of Assets
2.81-4.83234.572.35182.381.07
Upgrade
Asset Writedown
----35.3-10-
Upgrade
Other Unusual Items
0.221.80.160.050.10.46
Upgrade
Pretax Income
-171.85-129.99256.25-328.1484.77249.88
Upgrade
Income Tax Expense
231.32101.2186.97-32.7710.47143.01
Upgrade
Earnings From Continuing Operations
-403.17-231.2169.29-295.3774.3106.88
Upgrade
Minority Interest in Earnings
-60.01-52.74-25.34-15.4445.8892.43
Upgrade
Net Income
-463.18-283.93143.94-310.8120.17199.3
Upgrade
Net Income to Common
-463.18-283.93143.94-310.8120.17199.3
Upgrade
Net Income Growth
-----39.70%-19.53%
Upgrade
Shares Outstanding (Basic)
878787878787
Upgrade
Shares Outstanding (Diluted)
878787878787
Upgrade
Shares Change (YoY)
-0.23%-0.23%0.23%-0.24%-0.21%0.07%
Upgrade
EPS (Basic)
-5.34-3.271.66-3.581.392.30
Upgrade
EPS (Diluted)
-5.34-3.271.66-3.581.382.29
Upgrade
EPS Growth
-----39.74%-19.37%
Upgrade
Free Cash Flow
-228.45-220.16-34.73-857.91-1,485375.77
Upgrade
Free Cash Flow Per Share
-2.63-2.54-0.40-9.89-17.084.31
Upgrade
Dividend Per Share
1.0001.0001.000-0.8501.500
Upgrade
Dividend Growth
-----43.33%-16.67%
Upgrade
Gross Margin
48.56%47.05%46.76%42.96%45.12%44.99%
Upgrade
Operating Margin
-2.27%-0.15%1.54%-3.16%-2.01%2.18%
Upgrade
Profit Margin
-10.22%-6.47%3.14%-6.57%2.52%3.70%
Upgrade
Free Cash Flow Margin
-5.04%-5.01%-0.76%-18.14%-31.16%6.98%
Upgrade
EBITDA
51.54153.46235.757.0460.33278.32
Upgrade
EBITDA Margin
1.14%3.50%5.13%0.15%1.27%5.17%
Upgrade
D&A For EBITDA
154.58160.18165.14156.57156.01160.97
Upgrade
EBIT
-103.04-6.7270.61-149.54-95.68117.36
Upgrade
EBIT Margin
-2.27%-0.15%1.54%-3.16%-2.01%2.18%
Upgrade
Effective Tax Rate
--33.94%-12.35%57.23%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.